Clinical Trial Update: Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting safety and immunogenicity results from two doses of an H5N1 influenza vaccine in children, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza H5n1

Drugs mentioned

• H5N1 influenza vaccine (influenza vaccine H5N1)

Snippet

Sponsor: Novartis Vaccines | Conditions: Pandemic H5N1 Influenza | Phase 2 | Status: COMPLETED | Results posted: 2015-04-20